An extension of stochastic curtailment for incompletely reported and classified recurrent events: The Multicenter Study of Hydroxyurea in Sickle Cell Anemia (MSH)

O'Brien, 1979, A multiple testing procedure for clinical trials, Biometrics, 35, 549, 10.2307/2530245 Hallstrom, 1995, Toward vital status sweeps: a case history in sequential monitoring, Stat Med, 14, 1927, 10.1002/sim.4780141708 Karon, 1991, Using provisional diagnoses in monitoring a clinical trial, Stat Med, 10, 1341, 10.1002/sim.4780100903 Charache, 1995, Design of the multicenter study of hydroxyurea in sickle cell anemia, Controlled Clin Trials, 16, 432, 10.1016/S0197-2456(95)00098-4 Charache, 1995, Effect of hydroxyurea on the frequency of painful crises in sickle cell anema, N Engl J Med, 332, 1317, 10.1056/NEJM199505183322001 Conover, 1980, 316 Davis, 1994, Data monitoring in clinical trials: the case for stochastic curtailment, J Clin Epidemiol, 47, 1033, 10.1016/0895-4356(94)90119-8 Lan, 1988, The B-value: a tool for monitoring data, Biometrics, 44, 579, 10.2307/2531870 Kleinbaum, 1988, 497